Search research articles
Contact Us
Filters
Showing results (21-30 of 390) with videos related to
Page
of 39
Sort By:
Journal of Neuroimmunology
|
March 26, 2019
The role of vitamin D and P2X7R in multiple sclerosis
Veronica Tsin Fong Voo, Terence O'Brien, Helmut Butzkueven, et al.
Current Treatment Options in Neurology
|
April 25, 2018
Genotype and Phenotype in Multiple Sclerosis-Potential for Disease Course Prediction?
Vilija G Jokubaitis, Yuan Zhou, Helmut Butzkueven, et al.
Autoimmunity Reviews
|
April 22, 2017
Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: A systematic review
Bernd Merkel, Helmut Butzkueven, Anthony L Traboulsee, et al.
Autoimmunity Reviews
|
May 25, 2023
The impact of menopause on multiple sclerosis
Francesca Bridge, Helmut Butzkueven, Anneke Van der Walt, et al.
British Journal of Pharmacology
|
March 21, 2017
Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies
Ai-Lan Nguyen, Melissa Gresle, Tessa Marshall, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
September 15, 2022
Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool
Jeremy Hobart, Helmut Butzkueven, Jodi Haartsen, et al.
Glia
|
February 25, 2006
Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss
Helmut Butzkueven, Ben Emery, Tania Cipriani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 25, 2025
Impact of pregnancy on the maternal brain in health and multiple sclerosis
Jessica Shipley, Heidi Beadnall, Helmut Butzkueven, et al.
Multiple Sclerosis and Related Disorders
|
April 26, 2021
The development and impact of cladribine on lymphoid and myeloid cells in multiple sclerosis
Veronica Tsin Fong Voo, Helmut Butzkueven, Jim Stankovich, et al.
Neurorehabilitation
|
February 23, 2017
Gait and balance deterioration over a 12-month period in multiple sclerosis patients with EDSS scores ≤ 3.0
Mary P Galea, L Eduardo Cofré Lizama, Helmut Butzkueven, et al.
Page
of 39
Search research articles
Search
Showing results (21-30 of 390) with videos related to
Sort By:
Page
of 39
Journal of Neuroimmunology
|
March 26, 2019
The role of vitamin D and P2X7R in multiple sclerosis
Veronica Tsin Fong Voo, Terence O'Brien, Helmut Butzkueven, et al.
Current Treatment Options in Neurology
|
April 25, 2018
Genotype and Phenotype in Multiple Sclerosis-Potential for Disease Course Prediction?
Vilija G Jokubaitis, Yuan Zhou, Helmut Butzkueven, et al.
Autoimmunity Reviews
|
April 22, 2017
Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: A systematic review
Bernd Merkel, Helmut Butzkueven, Anthony L Traboulsee, et al.
Autoimmunity Reviews
|
May 25, 2023
The impact of menopause on multiple sclerosis
Francesca Bridge, Helmut Butzkueven, Anneke Van der Walt, et al.
British Journal of Pharmacology
|
March 21, 2017
Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies
Ai-Lan Nguyen, Melissa Gresle, Tessa Marshall, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
September 15, 2022
Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool
Jeremy Hobart, Helmut Butzkueven, Jodi Haartsen, et al.
Glia
|
February 25, 2006
Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss
Helmut Butzkueven, Ben Emery, Tania Cipriani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 25, 2025
Impact of pregnancy on the maternal brain in health and multiple sclerosis
Jessica Shipley, Heidi Beadnall, Helmut Butzkueven, et al.
Multiple Sclerosis and Related Disorders
|
April 26, 2021
The development and impact of cladribine on lymphoid and myeloid cells in multiple sclerosis
Veronica Tsin Fong Voo, Helmut Butzkueven, Jim Stankovich, et al.
Neurorehabilitation
|
February 23, 2017
Gait and balance deterioration over a 12-month period in multiple sclerosis patients with EDSS scores ≤ 3.0
Mary P Galea, L Eduardo Cofré Lizama, Helmut Butzkueven, et al.
Page
of 39